Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ARQT | Arcutis Biotherapeutics, Inc. | Chief Financial Officer | $541 K | Feb 13, 2024 | ||
GNLX | GENELUX Corp | Director | $48.2 K | -$18.7 K | -27.9% | May 29, 2024 |
AMTI | Applied Molecular Transport Inc. | Director | Dec 27, 2023 | |||
EFTR, EFTRW | eFFECTOR Therapeutics, Inc. | Director | Jun 22, 2023 | |||
NAMS, NAMSW | NewAmsterdam Pharma Co N.V. | Director | Jan 1, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|